Company / Profit Margin
TG Therapeutics, Inc. Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
72.6%
FY2025
5-year range
-8036.3% / 72.6%
FY2021-FY2025
Trend
+920.5%
vs FY2024
Sector context
#5 of 146
Health Care
What the data says
Profit Margin changed +921% YoY in FY2025, a notable deviation from the 7-year average annual change of +110%.
Based on SEC 10-K filings.
72.6% in FY2025 with a 5-year CAGR of +183875.8%. Top quartile in the Health Care sector.
Improved from 5.4% to 72.6% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +8108.9pp
- 5-Year Change
- +183875.8pp
- 10-Year Change
- -
Sector benchmark
Top 3% in Health CareTop 3% of 146This company 72.6% Sector average -796.3%
▼
+109.1% above sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 920.5% year-over-year.
- Currently 868.8pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 72.6% | +920.5% |
| FY2024 | 7.1% | +31.2% |
| FY2023 | 5.4% | +100.1% |
| FY2022 | -8036.3% | -54.4% |
| FY2021 | -5204.1% | +97.2% |
| FY2020 | -183803.3% | -135.8% |
| FY2019 | -77944.7% | -185.3% |
| FY2018 | -27321.7% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026